260 related articles for article (PubMed ID: 21976357)
1. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Basile I; Maynadier M; Vaillant O; Mongin O; Blanchard-Desce M; Morère A; Garcia M; Durand JO; Raehm L
Angew Chem Int Ed Engl; 2011 Nov; 50(48):11425-9. PubMed ID: 21976357
[No Abstract] [Full Text] [Related]
2. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.
Brevet D; Gary-Bobo M; Raehm L; Richeter S; Hocine O; Amro K; Loock B; Couleaud P; Frochot C; Morère A; Maillard P; Garcia M; Durand JO
Chem Commun (Camb); 2009 Mar; (12):1475-7. PubMed ID: 19277361
[TBL] [Abstract][Full Text] [Related]
3. Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy.
Hocine O; Gary-Bobo M; Brevet D; Maynadier M; Fontanel S; Raehm L; Richeter S; Loock B; Couleaud P; Frochot C; Charnay C; Derrien G; Smaïhi M; Sahmoune A; Morère A; Maillard P; Garcia M; Durand JO
Int J Pharm; 2010 Dec; 402(1-2):221-30. PubMed ID: 20934496
[TBL] [Abstract][Full Text] [Related]
4. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO
Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231
[TBL] [Abstract][Full Text] [Related]
5. Stem-Cell-Membrane Camouflaging on Near-Infrared Photoactivated Upconversion Nanoarchitectures for in Vivo Remote-Controlled Photodynamic Therapy.
Gao C; Lin Z; Wu Z; Lin X; He Q
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34252-34260. PubMed ID: 27936561
[TBL] [Abstract][Full Text] [Related]
6. Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging.
Qian J; Wang D; Cai F; Zhan Q; Wang Y; He S
Biomaterials; 2012 Jun; 33(19):4851-60. PubMed ID: 22484045
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, surface modification, characterization, and biomedical in vitro applications of organically modified silica (ORMOSIL) nanoparticles.
Diksha ; Roy I
Methods Mol Biol; 2012; 906():365-79. PubMed ID: 22791449
[TBL] [Abstract][Full Text] [Related]
8. Silica-based nanoparticles for photodynamic therapy applications.
Couleaud P; Morosini V; Frochot C; Richeter S; Raehm L; Durand JO
Nanoscale; 2010 Jul; 2(7):1083-95. PubMed ID: 20648332
[TBL] [Abstract][Full Text] [Related]
9. Functionalized silica-based nanoparticles for photodynamic therapy.
Couleaud P; Bechet D; Vanderesse R; Barberi-Heyob M; Faure AC; Roux S; Tillement O; Porhel S; Guillemin F; Frochot C
Nanomedicine (Lond); 2011 Aug; 6(6):995-1009. PubMed ID: 21726134
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic action of Rose Bengal silica nanoparticle complex on breast and oral cancer cell lines.
Uppal A; Jain B; Gupta PK; Das K
Photochem Photobiol; 2011; 87(5):1146-51. PubMed ID: 21749397
[TBL] [Abstract][Full Text] [Related]
11. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy.
Zhu J; Wang H; Liao L; Zhao L; Zhou L; Yu M; Wang Y; Liu B; Yu C
Chem Asian J; 2011 Sep; 6(9):2332-8. PubMed ID: 21744503
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin-based bridged silsesquioxane nanoparticles for targeted two-photon photodynamic therapy of zebrafish xenografted with human tumor.
Dib S; Aggad D; Mauriello Jimenez C; Lakrafi A; Hery G; Nguyen C; Durand D; Morère A; El Cheikh K; Sol V; Chaleix V; Dominguez Gil S; Bouchmella K; Raehm L; Durand JO; Boufatit M; Cattoën X; Wong Chi Man M; Bettache N; Gary-Bobo M
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1186. PubMed ID: 32721109
[TBL] [Abstract][Full Text] [Related]
13. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
[TBL] [Abstract][Full Text] [Related]
14. Silica-based nanoparticles are efficient delivery systems for temoporfin.
Brezániová I; Záruba K; Králová J; Sinica A; Adámková H; Ulbrich P; Poučková P; Hrubý M; Štěpánek P; Král V
Photodiagnosis Photodyn Ther; 2018 Mar; 21():275-284. PubMed ID: 29288831
[TBL] [Abstract][Full Text] [Related]
15. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT.
Gary-Bobo M; Hocine O; Brevet D; Maynadier M; Raehm L; Richeter S; Charasson V; Loock B; Morère A; Maillard P; Garcia M; Durand JO
Int J Pharm; 2012 Feb; 423(2):509-15. PubMed ID: 22178618
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of 5-aminolevulinic acid by multifunctional hollow mesoporous silica nanoparticles for photodynamic skin cancer therapy.
Ma X; Qu Q; Zhao Y
ACS Appl Mater Interfaces; 2015 May; 7(20):10671-6. PubMed ID: 25974979
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeling,
Er O; Tuncel A; Ocakoglu K; Ince M; Kolatan EH; Yilmaz O; Aktaş S; Yurt F
Mol Pharm; 2020 Jul; 17(7):2648-2659. PubMed ID: 32412765
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of Porphyrin to π-Conjugated Backbone for Polymer-Dot-Sensitized Photodynamic Therapy.
Chang K; Tang Y; Fang X; Yin S; Xu H; Wu C
Biomacromolecules; 2016 Jun; 17(6):2128-36. PubMed ID: 27219282
[TBL] [Abstract][Full Text] [Related]
19. Photosensitizer-incorporated G-quadruplex DNA-functionalized magnetofluorescent nanoparticles for targeted magnetic resonance/fluorescence multimodal imaging and subsequent photodynamic therapy of cancer.
Yin M; Li Z; Liu Z; Ren J; Yang X; Qu X
Chem Commun (Camb); 2012 Jul; 48(52):6556-8. PubMed ID: 22622597
[TBL] [Abstract][Full Text] [Related]
20. Sandwich-Structured Upconversion Nanoprobes Coated with a Thin Silica Layer for Mitochondria-Targeted Cooperative Photodynamic Therapy for Solid Malignant Tumors.
Song X; Yue Z; Hong T; Wang Z; Zhang S
Anal Chem; 2019 Jul; 91(13):8549-8557. PubMed ID: 31247732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
